PMDA — authorised 26 March 2019
- Marketing authorisation holder: SHIONOGI & CO., LTD.
- Status: approved
🇯🇵 Vyvanse in Japan
PMDA authorised Vyvanse on 26 March 2019
Marketing authorisation
Vyvanse in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in Japan
Frequently asked questions
Is Vyvanse approved in Japan?
Yes. PMDA authorised it on 26 March 2019.
Who is the marketing authorisation holder for Vyvanse in Japan?
SHIONOGI & CO., LTD. holds the Japanese marketing authorisation.